Dongwha Pharm.Co.Ltd (000020) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.002x

Based on the latest financial reports, Dongwha Pharm.Co.Ltd (000020) has a cash flow conversion efficiency ratio of 0.002x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩697.02 Million ≈ $472.36K USD) by net assets (₩409.65 Billion ≈ $277.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 000020 equity financing ratio to measure how much of total assets are equity-financed.

Dongwha Pharm.Co.Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Dongwha Pharm.Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Dongwha Pharm.Co.Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Dongwha Pharm.Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dongwha Pharm.Co.Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Lorne Park Capital Partners Inc V:LPC	0.058x
LUDWIG BECK am Rathauseck - Textilhaus Feldmeier AG XETRA:ECK	-0.052x
Fast Ejendom CO:FED	0.010x
Bastei Lübbe AG XETRA:BST	-0.015x
Kbi Metal Co. Ltd KQ:024840	0.043x
11 bit studios S.A WAR:11B	0.109x
KidariStudio Inc KO:020120	0.032x
Stabilis Solutions Inc NASDAQ:SLNG	0.197x

Annual Cash Flow Conversion Efficiency for Dongwha Pharm.Co.Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Dongwha Pharm.Co.Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Dongwha Pharm.Co.Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩401.44 Billion ≈ $272.05 Million	₩15.70 Billion ≈ $10.64 Million	0.039x	+492.38%
2024-12-31	₩401.68 Billion ≈ $272.21 Million	₩-4.00 Billion ≈ $-2.71 Million	-0.010x	-113.91%
2023-12-31	₩407.06 Billion ≈ $275.86 Million	₩29.17 Billion ≈ $19.77 Million	0.072x	-7.15%
2022-12-31	₩378.67 Billion ≈ $256.62 Million	₩29.22 Billion ≈ $19.80 Million	0.077x	-22.87%
2021-12-31	₩360.13 Billion ≈ $244.06 Million	₩36.03 Billion ≈ $24.42 Million	0.100x	-34.35%
2020-12-31	₩342.68 Billion ≈ $232.23 Million	₩52.23 Billion ≈ $35.39 Million	0.152x	+245.17%
2019-12-31	₩300.87 Billion ≈ $203.90 Million	₩13.28 Billion ≈ $9.00 Million	0.044x	+401.18%
2018-12-31	₩297.40 Billion ≈ $201.54 Million	₩-4.36 Billion ≈ $-2.95 Million	-0.015x	+73.65%
2017-12-31	₩296.94 Billion ≈ $201.24 Million	₩-16.52 Billion ≈ $-11.20 Million	-0.056x	-155.22%
2016-12-31	₩252.93 Billion ≈ $171.40 Million	₩25.48 Billion ≈ $17.27 Million	0.101x	+16.90%
2015-12-31	₩230.12 Billion ≈ $155.95 Million	₩19.83 Billion ≈ $13.44 Million	0.086x	+46.50%
2014-12-31	₩229.73 Billion ≈ $155.68 Million	₩13.51 Billion ≈ $9.16 Million	0.059x	+62.92%
2013-12-31	₩227.23 Billion ≈ $153.99 Million	₩8.21 Billion ≈ $5.56 Million	0.036x	-67.51%
2012-12-31	₩226.99 Billion ≈ $153.83 Million	₩25.23 Billion ≈ $17.10 Million	0.111x	-44.82%
2011-12-31	₩229.62 Billion ≈ $155.61 Million	₩46.24 Billion ≈ $31.34 Million	0.201x	--

About Dongwha Pharm.Co.Ltd

KO:000020 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$87.91 Million

₩129.72 Billion KRW

Market Cap Rank

#19583 Global

#954 in Korea

Share Price

₩4680.00

Change (1 day)

+2.07%

52-Week Range

₩4550.00 - ₩6670.00

All Time High

₩28554.43